Tryptamine induces tryptophanyl-tRNA synthetase-mediated neurodegeneration with neurofibrillary tangles in human cell and mouse models

NeuroMolecular Medicine

Volumn 9, Issue 1, 2007, Pages 55-82

  Paley, Elena L ^a,b   Denisova, Galina ^c   Sokolova, Olga ^d   Posternak, Natalia ^b   Wang, Xukui ^e   Brownell, Anna Liisa ^e  

^a NORTHWESTERN UNIVERSITY   (United States)

^b Expert Medical Transcription Inc   (United States)

^c MCMASTER UNIVERSITY   (Canada)

^d BRANDEIS UNIVERSITY   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRYPTAMINE; TRYPTOPHAN DERIVATIVE; TRYPTOPHAN TRANSFER RNA;

AMINO TERMINAL SEQUENCE; AMINOACYLATION; AMYLOIDOSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CATALYSIS; CELL DEGENERATION; CELL LOSS; COMPETITIVE INHIBITION; CONTROLLED STUDY; FOOD; GLIA CELL; HIPPOCAMPUS; HUMAN; HUMAN CELL; IN VITRO STUDY; KIDNEY CELL; NEPHROTOXICITY; NERVE CELL; NERVE DEGENERATION; NEUROFIBRILLARY TANGLE; NEUROPATHY; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BEHAVIOR, ANIMAL; BRAIN; CELL COUNT; CELL LINE, TUMOR; GLUCOSE; HIPPOCAMPUS; HUMANS; MALE; MICE; MICE, INBRED BALB C; MOTOR ACTIVITY; NEURODEGENERATIVE DISEASES; NEUROFIBRILLARY TANGLES; NEUROGLIA; NEURONS; TRYPTAMINES; TRYPTOPHAN-TRNA LIGASE;

EID: 33751095355     PISSN: 15351084     EISSN: None     Source Type: Journal    
DOI: 10.1385/NMM:9:1:55     Document Type: Article

References (98)

1. Abu-Shakra A. (1992) The modulatory effects of tryptamine and tyramine on the S9-mediated mutagenesis of IQ and MeIQ in Salmonella strain TA98. Teratog. Carcinog. Mutagen 12, 187-196.
2. Adeghate E. and Parvez H. (2004) The effect of diabetes mellitus on the morphology and physiology of monoamine oxidase in the pancreas. Neurotoxicology 25, 167-173.
3. Anderson G. M., Gerner R. H., Cohen D. J., and Fairbanks L. (1984) Central tryptamine turnover in depression, schizophrenia, and anorexia: measurement of indoleacetic acid in cerebrospinal fluid. Biol. Psychiatry 19, 1427-1435.
4. Arpi M., Vancanneyt M., Swings J., and Leisner J. J. (2003) Six cases of Lactobacillus bacteraemia: identification of organisms and antibiotic susceptibility and therapy. Scand. J. Infect. Dis. 35, 404-408.
5. Arriagada P. V., Growdon J. H., Hedley-Whyte E. T., and Hyman B. T. (1992) Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology 42, 631-639.
6. Badria F. A. (2002) Melatonin, serotonin, and tryptamine in some Egyptian food and medicinal plants. J. Med. Food 5, 153-157.
7. Bailey S. R., Menzies-Gow N. J., Marr C. M., and Elliott J. (2004) The effects of vasoactive amines found in the equine hindgut on digital blood flow in the normal horse. Equine Vet. J. 36, 267-372.
8. Bardsley W. G., Solano-Munoz F., Wright A. J., and McGinlay P. B. (1983) Inhibition of enzyme-catalysed reactions by excess substrate. A theoretical and Monte Carlo study of turning points in v(S) graphs. J. Mol. Biol. 169, 597-617.
9. Biedler J., Helson L., and Spengler B. A. (1973) Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture. Cancer Res. 33, 2643-2652.
10. Bover-Cid S., Hugas M., Izquierdo-Pulido M., and Vidal-Carou M. C. (2001) Amino acid-decarboxylase activity of bacteria isolated from fermented pork sausages. Int. J. Food Microbiol. 66, 185-189.
11. Bremer H. J., Anninos A., and Schultz B. (1996) Amino acid composition of food products used in the treatment of patients with disorders of the amino acid and protein metabolism. Eur. J. Pediatr. 155, S108-S114.
12. Carantoni M., Zuliani G., Munari M. R., D'Elia K., Palmieri E., and Fellin R. (2000) Alzheimer disease and vascular dementia: relationships with fasting glucose and insulin levels. Dement. Geriatr. Cogn. Disord. 11, 176-180.
13. Chanut E., Trouvin J. H., Bondoux D., Gardier A., Launay J. M., and Jacquot C. (1993) Metabolism of 6-fluoro-DL-tryptophan and its specific effects on the rat brain serotoninergic pathway. Biochem. Pharmacol. 45, 1049-1057.
14. Cherin P. (1999) Treatment of inclusion body myositis. Curr. Opin. Rheumatol. 11, 456-461.
15. Cox B., Lee T. F., and Martin D. (1981) Different hypothalamic receptors mediate 5-hydroxytryptamine- and tryptamine-induced core temperature changes in the rat. Br. J. Pharmacol. 72, 477-482.
16. Davis P. K. and Johnson G. V. W. (1999) Energy metabolism and protein phosphorylation during apoptosis: a phosphorylation study of tau and high-molecular-weight tau in differentiated PC12 cells. Biochem. J. 340, 51-58.
17. Demling J., Langer K., and Mehr M. Q. (1996) Age dependence of large neutral amino acid levels in plasma. Focus on Tryptophan, in The Recent Advances in Tryptophan Research, Filippini, G. A. ed., Plenum Press, New York, pp. 579-582.
18. De Santi S., de Leon M. J., Rusinek H., et al. (2001) Hippocampal formation glucose metabolism and volume losses in MCI and AD. Neurobiol. Aging 22, 529-539.
19. Dewhurst W. G. (1968) New theory of cerebral amine function and its clinical application. Nature 218, 1130-1133.
20. Domino E. F. and Gahagan S. (1977) In vitro half-life of 14-C-tryptamine in whole blood of drug-free chronic schizophrenic patients. Am. J. Psychiatry 134, 1280-1282.
21. Erkmen O. and Bozkurt H. (2004) Quality characteristics of retailed sucuk (Turkish dry-fermented sausage). Food Technol. Biotechnol. 42, 63-69.
22. Favorova O. O., Zargarova T. A., Rukosuyev V. S., Beresten S. F., and Kisselev L. L. (1989) Molecular and cellular studies of tryptophanyl-tRNA synthetases using monoclonal antibodies. Remarkable variations in the content of tryptophanyl-tRNA synthetase in the pancreas of different mammals. Eur. J. Biochem. 184, 583-588.
23. Fekkes D., van der Cammen T. J., van Loon C. P., et al. (1998) Abnormal amino acid metabolism in patients with early stage Alzheimer dementia. J. Neural Transm. 105, 287-294.
24. Fischer Y., Thomas J., Kamp J., et al. (1995) 5-hydroxytryptamine stimulates glucose transport in cardiomyocytes via a monoamine oxidase-dependent reaction. Biochem. J. 311, 575-583.
25. Fletcher P. J. and Paterson I. A. (1989) A comparison of the effects of tryptamine and 5-hydroxytryptamine on feeding following injection into the paraventricular nucleus of the hypothalamus. Pharmacol. Biochem. Behav. 32, 907-911.
26. Flinn J. P. III. and Edwards R. H. (1998) Multiple residues contribute independently to differences in ligand recognition between vesicular monoamine transporters 1 and 2. J. Biol. Chem. 273, 3943-3947.
27. Forsstrom T., Tuominen J., and Karkkainen J. (2001) Determination of potentially hallucinogenic N-dimethylated indoleamines in human urine by HPLC/ESI-MS-MS. J. Scan. J. Clin. Lab. Invest. 61, 547-556.
28. Fromant M., Fayat G., Laufer P., and Blanquet S. (1981) Affinity chromatography of aminoacyl-tRNA syntheses on agarose-hexyl-adenosine-5′- phosphate. Biochimie 63, 541-553.
29. Gallyas F. (1970) Silver staining of Alzheimer's neurofibrillary changes by means of physical development. Acta Morphol. Acad. Sci. Hung. 19, 1-8.
30. rd., Sparkman D. R. (1987) Alzheimer's disease: neurofibrillary tangles in nuclei that project to the cerebral cortex. Neuroscience 21, 305-312.
31. Gilbert J. A., Bates L. A., and Ames M. M. (1995) Elevated aromatic-L-amino acid decarboxylase in human carcinoid tumors. Biochem. Pharmacol. 50, 845-850.
32. Gomez-Isla T., Hollister R., West H. L., et al. (1997) Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease. Ann. Neurol. 41, 17-24.
33. Gomes-Ramos P. and Moran M. A. (1998) Ultrastructural aspects of neurofibrillary tangle formation in aging and Alzheimer's disease. Micros. Res. Tech. 43, 49-58.
34. Gotz J., Schild A., Hoerndli F., and Pennanen L. (2004) Amyloid-induced neurofibrillary tangle formation in Alzheimer's disease: insight from transgenic mouse and tissue-culture models. Int. J. Dev. Neurosci. 22, 453-465.
35. Hamacher K., Coenen H. H., and Stocklin G. (1986) Efficient stereospecific synthesis of no-carrier added 2-[18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution. J. Nuclear Med. 27, 235-238.
36. Harris F. M., Brecht W. J., Xu Q., et al. (2003) Carboxyl-terminal- truncated apolipoprotein E4 causes Alzheimer's disease-like neurodegeneration and behavioral deficits in transgenic mice. Proc. Natl. Acad. Sci. USA 100, 10,966-10,971.
37. Helene C., Dimicoli J. L., and Brun F. (1971) Binding of tryptamine and 5-hydroxytryptamine (serotonin) to nucleic acids. Fluorescence and proton magnetic resonance studies. Biochemistry 10, 3802-3809.
38. Huang Y., Liu X. Q., Wyss-Coray T., Brecht W. J., Sanan D. A., and Mahley R. W. (2001) Apolipoprotein E fragments present in Alzheimer's disease brains induce neurofibrillary tangle-like intracellular inclusions in neurons. Proc. Natl. Acad. Sci. USA 98, 8838-8843.
39. Jacob J. and Michaud G. (1962) Effect of 5-hydroxytrptamine and nicotine on hypertension induced by 5-hydroxytryptamine, nicotine, tryptamine and acetaldehyde. Arch. Int. Pharmacodyn. Ther. 140, 92-104.
40. Jones R. S. (1982) A comparison of the responses of cortical neurones to iontophoretically applied tryptamine and 5-hydroxytryptamine in the rat. Neuropharmacology 21, 209-214.
41. Juorio A. V. and Durden D. A. (1984) The distribution and turnover of tryptamine in the brain and spinal cord. Neurochem. Res. 9, 1283-1293.
42. Kalac P. and Krizek M. (2003) A review of biogenic amines and polyamines in beer. J. Inst. Brew. 109, 123-128.
43. Kalac P., Svecova S., and Pelikanova T. (2002) Food Chem. 77, 349-351.
44. Kisselev L. L., Favorova O. O., and Kovaleva G. K. (1979) Tryptophanyl-tRNA synthetase from beef pancreas. Methods Enzymol. 59 (G), 234-257.
45. Lee V. M.-Y., Balin B. J., Otvos L. Jr., and Trojanowski J. Q. (1991) A68: a major subunit of paired helical filaments and derivatized forms of normal tau. Science 251, 675-678.
46. Levchenko A., Robitaille Y., Strong M. J., and Rouleau G. A. (2004) TAU mutations are not a predominant cause of frontotemporal dementia in Canadian patients. Can. J. Neurol. Sci. 31, 363-367.
47. Lewin A. H. (2006) Receptors of Mammalian Trace Amines. The AAPS J. 8, E138-E145.
48. Liberski P. P., Yanagihara R., Gibbs C. J. Jr., and Gajdusek D. C. (1992) Neuronal autophagic vacuoles in experimental scrapie and Creutzfeld-Jacob disease. Acta Neuropathol. 83, 134-139.
49. Lowe G. and Tansley G. (1984) An investigation of the mechanism of activation of tryptophan by tryptophanyl-tRNA synthetase from beef pancreas. Eur. J. Biochem. 138, 597-602.
50. Martuscelli M., Crudele M. A., Gardini F., and Suzzi G. (2000) Biogenic amine formation and oxidation by Staphylococcus xylosus strains from artisanal fermented sausages. Lett. Appl. Microbiol. 31, 228-232.
51. Mattson M. P. and Sherman M. (2003) Perturbed signal transduction in neurodegenerative disorders involving aberrant protein aggregation. Neuromol. Med. 4, 109-132.
52. McDonald W. M., Holtzheimer P. E., and Byrd E. H. (2006) The diagnosis and treatment of depression in Parkinson's disease. Curr. Treat Options Neurol. 8, 245-255.
53. Miklossy J., Taddei K., Martins R., et al. (1999) Alzheimer disease: curly fibers and tangles in organs other than brain. J. Neuropathol. Exp. Neurol. 58, 803-814.
54. Mimnaugh E. G., Xu W., Vos M., et al. (2004) Simultaneous inhibition of hsp 90 and the proteasome promotes protein ubiquitination, causes endoplasmic reticulum-derived cytosolic vacuolization, and enhances antitumor activity. Mol. Cancer Ther. 3, 551-566.
55. Mizunoya W., Oyaizu S., Hirayama A., and Fushiki T. (2004) Effects of physical fatigue in mice on learning performance in a water maze. Biosci. Biotechnol. Biochem. 4, 827-834.
56. Molina J. A., Jimenez-Jimenez F. J., Gomez P., et al. (1997) Decreased cerebrospinal fluid levels of neutral and basic amino acids in patients with Parkinson's disease. J. Neurol. Sci. 150, 123-127.
57. Mousseau D. D. (1993) Tryptamine: a metabolite of tryptophan implicated in various neuropsychiatric disorders. Matab. Brain Dis. 8, 1-44.
58. Mousseau D. D. and Butterworth R. F. (1994) The [3H]tryptamine receptor in human brain: kinetics, distribution, and pharmacologic profile. J. Neurochem. 63, 1052-1059.
59. Mousseau D. D. and Butterworth R. F. (1995) Trace amines in hepatic encephalopathy, in The Progress in Brain Research, vol. 106, Yu, P. M., Tipton, K. F., and Boulton A. A., eds., Elsevier Science, Amsterdam, pp. 277-284.
60. Nemecek G. M., Coughlin S. R., Handley D. A., and Moskowitz M. A. (1986) Stimulation of aortic smooth muscle cell mitogenesis by serotonin. Proc. Natl. Acad. Sci. USA 83, 674-678.
61. Newmester A., Haberler A., Praschak-Rieder N., Willeit M., and Kasper S. (1999) Tryptophan depletion: a predictor of future depressive episodes in seasonal affective disorder? Int. Clin. Psychopharmacol. 14, 313-315.
62. Nishimura M., Namba Y., Ikeda K., and Oda M. (1992) Glial fibrillary tangles with straight tubulus in the brains of patients with progressive supranuclear palsy. Neurosci. Lett. 143, 35-38.
63. Novella-Rodriguez S., Veciana-Nogues M. T., Roig-Sagues A. X., Trujillo-Mesa, A. J., and Vidal-Carou M. C. (2002) Influence of starter and nonstarter on the formation of biogenic amine in goat cheese during ripening. J. Dairy Sci. 85, 2471-2478.
64. O'Kane R. L. and Hawkins R. A. (2003) Na+-dependent transport of large neutral amino acids occurs at the abluminal membrane of the blood-brain barrier. Am. J. Physiol. Endocrinol. Metab. 285, 1167-1173.
65. Okuyama S., Chaki S., Yoshikawa R., et al. (1997) In vitro and in vivo characterization of the dopamine D4 receptor, serotonin 5-HT2A receptor and alpha-1 adrenoceptor antagonist (R)-(+)-2-amino-4-(4-fluorophenyl)-5-[1-[4-(4- fluorophenyl)-4-oxobutyl] pyrrolidin-3-yl]thiazole (NRA0045). J. Pharmacol. Exp. Ther. 282, 56-63.
66. Paley E. L. (1997) A mammalian tryptophanyl-tRNA synthetase is associated with protein kinase activity. Eur. J. Biochem. 244, 780-788.
67. Paley E. L. (1999) Tryptamine-mediated stabilization of tryptophanyl-tRNA synthetase in human cervical carcinoma cell line (1999) Cancer Lett. 137, 1-7.
68. Paley E. L., Alexandrova N., and Smelansky L. (1995) Tryptophanyl-tRNA synthetase as a human antigen. Immunol. Lett. 48, 201-207.
69. Paley E. L., Baranov V. N., Alexandrova N. M., and Kisselev L. L. (1991) Tryptophanyl-tRNA synthetase in cell lines resistant to tryptophan analogs. Exp. Cell Res. 195, 66-78.
70. 2 and COOH termini of mammalian tryptophanyl-tRNA synthetase reveal link of the epitopes to aggregation and Alzheimer's disease. Mol. Immunol. In press.
71. Perani D., Bressi S., Cappa S. F., et al. (1993) Evidence of multiple memory systems in the human brain. A [18F]FDG PET metabolic study. Brain 116, 903-919.
72. Porter R. J., Lunn B. S., and O'Brien J. T. (2003) Effects of acute tryptophan depletion on cognitive function in Alzheimer's disease and in the healthy elderly. Psychol. Med. 33, 41-49.
73. Riederer P., Danielczyk W., and Grunblatt E. (2004) Monoamine oxidase-B inhibition in Alzheimer's disease. Neutoxicology 25, 271-277.
74. Rosenblum W. I. (1999) The presence, origin, and significance of A beta peptide in the cell bodies of neurons. J. Neuropathol. Exp. Neurol. 58, 575-581.
75. Rowe S. K. and Rapaport M. H. (2006) Classification and treatment of sub-threshold depression. Curr. Opin. Psychiatry 19, 9-13.
76. Rubin B. Y., Anderson S. L., Xing L., Powell R., and Tate W. P. (1991) Interferon induces tryptophanyl-tRNA synthetase expression in human fibroblasts. J. Biol. Chem. 266, 24,245-24,248.
77. Sari Y. and Zhou F. C. (2004) Prenatal alcohol exposure causes long-term serotonin neuron deficit in mice. Alcoholism: clinical and experimental research. Alcohol Clin. Exp. Res. 28, 941-948.
78. Shalaby A. R. (2000) Changes in biogenic amines in mature and germinating legume seeds and their behavior during cooking. Nahrung 44, 23-27.
79. Spillantini M. G. and Goedert M. (1998) Tau protein pathology in neurodegenerative diseases. Trends Neurosci. 21, 428-433.
80. Smith G., Vigen V., Evans J., Fleming K., and Bohac D. (1998) Patterns and associates of hyperphagia in patients with dementia. Neuropsychiatr. Neuropsychol. Behav. Neurol. 11, 97-102.
81. Sokolova O., Accardi A., Gutierrez D., Lau A., Rigney M., and Grigorieff N. (2003) Conformational changes in the C terminus of Shaker K+ channel bound to the rat Kvbeta2-subunit. Proc. Natl. Acad. Sci. USA 100, 12,607-12,612.
82. Starkstein S. E., Jorge R., Mizrahi R., and Robinson R. G. (2005) The construct of minor and major depression in Alzheimer's disease. Am. J. Psychiatry 162, 2086-2093.
83. Sugimoto Y., Kimura I., Yamada J., Watanabe Y., and Horisaka K. (1994) Effects of tryptamine on plasma glucagon levels in mice. Neurochem. Res. 19, 15-18.
84. Sugimoto Y., Kimura I., Yamada J., Watanabe Y., Takeuchi N., and Horisaka K. (1991) The involvement of insulin in tryptamine-induced hypoglycemia in mice. Life Sci. 48, 1679-1683.
85. Sullivan J. L., Coffey C. E., Basuk B., Cavenar J. O., Maltbie A. A., and Zung W. W. (1980) Urinary tryptamine excretion in chronic schizophrenics with low platelet MAO activity. Biol. Psychiatry 15, 113-120.
86. Tabaton M., Cammarata S., Mancardi G., et al. (1991) Ultrastructural localization of beta-amyloid, tau, and ubiquitin epitopes in extracellular neurofibrillary tangles. Proc. Natl. Acad. Sci. USA 88, 2098-2102.
87. Taylor M. W. and Feng G. S. (1991) Relationship between interferon-gamma, indoleamine 2,3-dioxygenase, and tryptophan catabolism. FASEB J. 11, 2516-2522.
88. Thomas J. C., Saleh E. F., Alammar N., and Akroush A. M. (1998) The indole alkaloid tryptamine impairs reproduction in Drosophila melanogaster. J. Econ. Entomol. 91, 841-846.
89. Tsuchiya H., Ohtani S., Yamada K., Tajima K. and Sato M. (1995) Formation of tetrahydro-beta-carbolines in human saliva. Biochem. Pharmacol. 50, 2109-2112.
90. Tuzikov F. V., Tuzikova N. A., Vavilin V. I., et al. (1991) Aggregation of tryptophanyl-tRNA synthetase depending on temperature. Study by a low-angle scatter X-ray method. Mol. Biol. (Mosk) 25, 740-751.
91. Valls J. E., Bello R. A., and Kodaira M. S. (2002) Semi-quantitative analysis by thin-layer chromatography (TLC) of biogenic amines in dried, salted and canned fish products. J. Food Qual. 26, 91-180.
92. von Gunten A., Kovari E., Bussiere T., et al. (2006) Cognitive impact of neuronal pathology in the entorhinal cortex and CA1 field in Alzheimer's disease. Neurobiol. Aging 27, 270-277.
93. Walter J., Hertel C., Tannock G. W., Lis C. M., Munro K., and Hammes W. P. (2001) Detection of Lactobacillus, Pediococcus, Leuconostoc, and Weissella species in human feces by using group-specific PCR primers and denaturing gradient gel electrophoresis. Appl. Environ. Microbiol. 67, 2578-2585.
94. Weiner M. F., Hynan L. S., Parikh B., et al. (2003) Can Alzheimer's disease and dementias with Lewy bodies be distinguished clinically? J. Geriatr. Psychiatr. Neurol. 16, 245-250.
95. Yamada J., Sugimoto Y., and Horisaka K. (1987a) The behavioral effects of intravenously administered tryptamine in mice. Neuropharmacology 26, 49-53.
96. Yamada J., Wakita H., Sugimoto Y., and Horisaka K. (1987b) Hypothermia induced in mice by intracerebroventricular injection of tryptamine: involvement of the 5-HT1 receptor. Eur. J. Pharmacol. 139, 117-119.
97. Yoshida M., Goto K., and Watanabe S. (2001) Task-dependent strain difference of spatial learning in C57BL/6N and BALB/c mice. Physiol. Behav. 73, 37-42.
98. Young E. A., Neff N. H., and Hadjiconstantinou M. (1994) Phorbol ester administration transiently increases aromatic L-amino acid decarboxylase activity of the mouse striatum and midbrain. J. Neurochem. 63, 694-697.